Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-000708-18-PT
EUCTR2006-000708-18-PT
Active, not recruiting
Not Applicable

Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - SHIFT

Institut de Recherches Internationales Servier0 sites6,500 target enrollmentMarch 5, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionscardiac failure chronicMedDRA version: 9.0Level: PTClassification code 10007558
DrugsPROCORALAN

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
cardiac failure chronic
Sponsor
Institut de Recherches Internationales Servier
Enrollment
6500
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 5, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- male or female patients \>\= 18 years
  • •\- Chronic Heart Failure
  • •\- left ventricular systolic dysfunction
  • •\- sinus rythm
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •\- unstable cardiovascular condition
  • •\- recent myocardial infarction or coronary revascularisation
  • •\- congenital heart diseases
  • •\- severe valvular disease
  • •\- active myocarditis

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - SHIFT
EUCTR2006-000708-18-NLInstitut de Recherches Internationales Servier5,500
Active, not recruiting
Phase 1
Effects of ivabradine on cardiovascular events in patients with stable coronary artery disease and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - BEAUTIF
EUCTR2004-001959-11-SKInstitut de Recherches Internationales Servier9,650
Active, not recruiting
Not Applicable
Effects of ivabradine on cardiovascular events in patients with stable coronary artery disease and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - BEAUTIFCoronary artery diseaseMedDRA version: 7.0Level: PTClassification code 10011078
EUCTR2004-001959-11-FIInstitut de Recherches Internationales9,650
Active, not recruiting
Not Applicable
Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - SHIFT
EUCTR2006-000708-18-CZInstitut de Recherches Internationales Servier6,500
Active, not recruiting
Not Applicable
Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - SHIFTcardiac failure chronicMedDRA version: 9.0Level: PTClassification code 10007558
EUCTR2006-000708-18-ATInstitut de Recherches Internationales Servier6,500